Drug Retention Rates and the Safety of Janus Kinase Inhibitors in Elderly Patients with Rheumatoid Arthritis

Background: We examined the real-world drug retention rate and safety data of Janus kinase inhibitors (JAKis) in elderly patients with rheumatoid arthritis (RA). Methods: This study enrolled 133 RA patients (≥65 years) with sufficient clinical data who were initiated with JAKis during the study peri...

Descripción completa

Detalles Bibliográficos
Autores principales: Temmoku, Jumpei, Miyata, Masayuki, Suzuki, Eiji, Sumichika, Yuya, Saito, Kenji, Yoshida, Shuhei, Matsumoto, Haruki, Fujita, Yuya, Matsuoka, Naoki, Asano, Tomoyuki, Sato, Shuzo, Migita, Kiyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380728/
https://www.ncbi.nlm.nih.gov/pubmed/37510700
http://dx.doi.org/10.3390/jcm12144585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380728/
https://www.ncbi.nlm.nih.gov/pubmed/37510700
http://dx.doi.org/10.3390/jcm12144585

Ejemplares similares